English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52882028    Online Users :  679
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"wei yu liao"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 31-55 of 133  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-07-21T06:09:13Z Modulating chemotaxis of lung cancer cells by using electric fields in a microfluidic device Kao Y.-C.;Hsieh M.-H.;Liu C.-C.;Pan H.-J.;Wei-Yu Liao;Cheng J.-Y.;Kuo P.-L.;Lee C.-H.; Kao Y.-C.; Hsieh M.-H.; Liu C.-C.; Pan H.-J.; WEI-YU LIAO; Cheng J.-Y.; Kuo P.-L.; Lee C.-H.
臺大學術典藏 2020-07-21T06:09:13Z Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer Yang J.C.-H.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO; Yang P.-C.; Chen H.-Y.; Hsu W.-H.; Lin Y.-L.; Lee J.-H.; Lee J.-H.;Lin Y.-L.;Hsu W.-H.;Chen H.-Y.;Chang Y.-C.;Yu C.-J.;Shih J.-Y.;Lin C.-C.;Chen K.-Y.;Ho C.-C.;Wei-Yu Liao;Yang P.-C.;Yang J.C.-H.
臺大學術典藏 2020-07-21T06:09:13Z Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal study Liao Y.-C.; Shun S.-C.; WEI-YU LIAO; Yu C.-J.; Yang P.-C.; Lai Y.-H.
臺大學術典藏 2020-07-21T06:09:12Z Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer Yang P.-C.; Lee C.-H.; Yu C.-J.; Hou H.-H.; Hsu T.-H.; Tsai M.-F.; Chen K.-Y.; Chen H.-Y.; Lee Y.-C.; Ho C.-C.; WEI-YU LIAO
臺大學術典藏 2020-07-21T06:09:12Z GM2-activator protein: A new biomarker for lung cancer Potprommanee L.; Ma H.-T.; Shank L.; Juan Y.-H.; WEI-YU LIAO; Chen S.-T.; Yu C.-J.
臺大學術典藏 2020-07-21T06:09:11Z EGFR mutation and lobar location of lung adenocarcinoma Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; WEI-YU LIAO; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.; Chen H.-J.; Wu T.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.
臺大學術典藏 2020-07-21T06:09:11Z Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib Liu Y.-N.; Shih J.-Y.; WEI-YU LIAO; Gow C.-H.
臺大學術典藏 2020-07-21T06:09:10Z Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases Keng L.-T.; Lee H.-S.; Chang H.-T.; WEI-YU LIAO; Ho C.-C.; Yu C.-J.; Hsieh S.-C.; Lin C.-H.
臺大學術典藏 2020-07-21T06:09:10Z Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Wei-Yu Liao;Yu K.-L.;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; WEI-YU LIAO; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏 2020-07-21T06:09:09Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Yu C.-J.; Yang J.C.H.; Yao Z.-H.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.; Yao Z.-H.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.
臺大學術典藏 2020-07-21T06:09:09Z Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib Chih-Hsin Yang J.; Yu C.-J.; Ho C.-C.;Wei-Yu Liao;Lin C.-A.;Shih J.-Y.;Yu C.-J.;Chih-Hsin Yang J.; Ho C.-C.; WEI-YU LIAO; Lin C.-A.; Shih J.-Y.
臺大學術典藏 2020-07-21T06:09:09Z Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study Hsieh M.-J.; Wu W.-S.; Chen Y.-M.; Tsai Y.-H.; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; WEI-YU LIAO; Liu C.-Y.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Hsu K.-H.; Yu C.-J.; Yang C.-T.; Tseng C.-H.; Chang G.-C.; Chang G.-C.;Tseng C.-H.;Hsu K.-H.;Yu C.-J.;Yang C.-T.;Chen K.-C.;Yang T.-Y.;Tseng J.-S.;Liu C.-Y.;Wei-Yu Liao;Hsia T.-C.;Tu C.-Y.;Lin M.-C.;Tsai Y.-H.;Hsieh M.-J.;Wu W.-S.;Chen Y.-M.
臺大學術典藏 2020-07-21T06:09:08Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Wei-Yu Liao;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; WEI-YU LIAO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2020-07-21T06:09:07Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Hsu F.-M.; Yang P.-C.; Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Wei-Yu Liao;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.; Cheng J.C.-H.; Kuo S.-H.
臺大學術典藏 2020-07-21T06:09:06Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Wei-Yu Liao;Ho C.-C.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; WEI-YU LIAO; Ho C.-C.; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2020-07-21T06:09:06Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Wei-Yu Liao;Ho C.-C.;Tsai T.-H.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.
臺大學術典藏 2020-07-21T06:09:06Z Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients Shih J.-Y.; Ho C.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Wei-Yu Liao;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.
臺大學術典藏 2020-07-21T06:09:05Z The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer Yu K.-L.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Lin C.-K.; Hsu C.-L.; Shih J.-Y.; Yu K.-L.;Tsai T.-H.;Ho C.-C.;Wei-Yu Liao;Lin C.-K.;Hsu C.-L.;Shih J.-Y.
臺大學術典藏 2020-07-21T06:09:04Z Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma Yu C.-J.; Shih J.-Y.; WEI-YU LIAO; Hsieh M.-S.; Yang C.-Y.
臺大學術典藏 2020-07-21T06:09:04Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Yu C.-J.; Shih J.-Y.; Yang J.C.-H.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; WEI-YU LIAO; Chen J.-S.; Lin Y.-T.
臺大學術典藏 2020-07-21T06:09:03Z Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer Thress K.; Yang J.C.-H.; Stetson D.; Markovets A.; WEI-YU LIAO; Liao B.-C.; Hsu C.-C.; Hsu C.-C.;Liao B.-C.;Wei-Yu Liao;Markovets A.;Stetson D.;Thress K.;Yang J.C.-H.
臺大學術典藏 2020-07-21T06:09:03Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.
臺大學術典藏 2020-07-21T06:09:02Z Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells Hou H.-H.;Pan H.-J.;Wei-Yu Liao;Lee C.-H.;Yu C.-J.; Hou H.-H.; Pan H.-J.; WEI-YU LIAO; Lee C.-H.; Yu C.-J.
臺大學術典藏 2020-04-08T10:35:55Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Chia-Chi Hsu; Bin-Chi Liao; Wei-Hsun Hsu; Jih-Hsiang Lee; Chia-Chi Lin; Jin-Yuan Shih; James C.-H. Yang; Chong-Jen Yu; Ching-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chong-Jen Yu;James C.-H. Yang;Jin-Yuan Shih;Chia-Chi Lin;Jih-Hsiang Lee;Wei-Hsun Hsu;Bin-Chi Liao;Chia-Chi Hsu;Chen-Tu Wu;Yih-Leong Chang;Kang-Yi Su;Chia-Lin Hsu;Tzu-Hsiu Tsai;Kuan-Yu Chen;Chao-Chi Ho;Wei-Yu Liao;Ching-Yao Yang
臺大學術典藏 2020 Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer Lin W.-C.; Chuang C.-A.; WEI-YU LIAO; Lai C.-F.; Cho S.-L.; Cho S.-L.;Lin W.-C.;Chuang C.-A.;Wei-Yu Liao;Lai C.-F.

Showing items 31-55 of 133  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page